Skip to main content

HPV Vaccine Advocacy Resources

Global Priorities and Needs for HPV Vaccine Advocacy

IVAC conducted an online survey with approximately 100 global stakeholders to explore which topics, audiences, and approaches may be most important to inform future HPV vaccine advocacy. To advance the shared goal of accelerating cervical cancer elimination around the world, our findings about HPV vaccine advocacy are presented in a brief report.

Understanding Priorities and Needs for HPV Vaccine Advocacy: Findings from a Global Survey

HPV Advocacy Brief Thumbnail image

Suggested citation: International Vaccine Access Center (IVAC), Understanding Priorities and Needs for HPV Vaccine Advocacy: Findings from a Global Survey, IVAC at the Johns Hopkins Bloomberg School of Public Health, Baltimore, May 2023.

Executive Summary

Thumbnail of Executive Summary on HPV Vaccine Advocacy

Country Toolkits and Case Studies

We also conducted a series of key informant interviews in two countries, Ghana and Indonesia, to better understand advocacy needs in these contexts. We created country-specific reports and toolkits based on our findings that can be used by in-country partners to advocate for HPV vaccine introduction.

Ghana Resources

Case Study: HPV Vaccine Advocacy in Ghana

Thumbnail of Advocacy brief on HPV in Ghana

HPV Vaccine Introduction in Ghana

Single-Dose HPV Vaccination in Ghana

What to Know About HPV Vaccines


Indonesia Resources

Case Study: HPV Vaccine Advocacy in Indonesia

Thumbnail of brief on HPV Vaccine Introduction in Indonesia

Prioritizing HPV Vaccines in Indonesia

Single-Dose HPV Vaccination in Indonesia

Advocacy Needs for HPV Vaccines in Indonesia